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Abstract —Different molecular forms of circulating prolactin (PRL) are known to occur in several 
species. As no such information was available in dogs, we assessed the molecular profile of circulating 
PRL in bitches. Pooled sera from covertly (CTRL) and overtly pseudopregnant (PSPT) diestrous 
bitches with high or low (> 10 or < 10 ng-nil, '. respectively) serum PRL (measured by ELISA) 
were analyzed by Sephadex G-100 and Concanavalin A-Sepharose column chromatography. Four 
serum PRL fractions were identified and termed big-big, big (> 67 kDa), native (23 kDa) and frag­
mented (< 20 kDa) PRL. The percentages of these fractions were roughly similar in CTRL and PSPT 
animals, irrespective of their serum PRL levels (higher in PSPT than in CTRL bitches). A large pro­
portion of glycosylated PRL (between 69 and 100%) was also detected in these sera. We conclude that 
in dogs, circulating PRL occurs in multiple molecular forms, whose relative abundance is compara­
ble in covertly and overtly pseudopregnant bitches.
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Résumé — Hétérogénéité de la prolactine circulante chez la chienne. La prolactine (PRL) circulante 
se trouve, dans différentes espèces, sous plusieurs formes moléculaires. Compte tenu du fait qu’il 
n’existe pas d’information disponible chez le chien, nous avons décidé d’étudier le profil moléculaire 
de la PRL circulante chez cet animal. Nous avons utilisé des pools de sérums provenant de chiennes 
normales en diestrus (CTRL) ou pseudogestantes (PSPT), ayant des taux élevés ou bas de PRL (> 10 
ou < 10 ng-nil, 1 respectivement; dosages effectués par Elisa). Les sérums ont été analysés sur 
colonne de Séphadex G-100 et par chromatographie d’affinité, sur colonne de Sépharose couplée à 
de la Concanavaline A. La chromatographie sur G-100 a identifié quatre fractions de PRL, qui ont
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été appelées big-big, big (PM < 67 kDa), native (23 kDa) et fragmentée (< 20 kDa). Les pourcentages 
relatifs de ces fractions sont identiques chez les CTRL et les PSPT, quel que soit le taux, élevé ou bas, 
de PRL sérique (plus haut chez les animaux CTRL). De plus, une proportion importante de PRL 
sérique (69 à 100 %) est sous fonne glycosylée. En conclusion, la PRL sérique se trouve, chez le chien, 
sous des tonnes moléculaires multiples, dont l’abondance relative est comparable chez la chienne nor­
male et pseudogestante.
prolactine / variant moléculaire / chienne / diestrus / pseudogestation
1. INTRODUCTION
Prolactin (PRL) is known to be a 197-198 
amino acid peptide with a mass of23-24 kDa. 
Research has uncovered a surprising degree 
of molecular heterogeneity for circulating 
PRL, with different biopotencies associated 
with varying molecular forms of the hor­
mone [24,25], Thus, small molecular weight 
PRL forms have been described, which may 
result from alternative splicing of the PRL 
gene’s primary transcript or proteolytic 
cleavage, which gives rise to fragments of 
22, 21, 17, 16 and 5.8 kDa [25], While the 
17 and 16 kDa variants exhibit a biopotency 
to immunoreactivity ratio similar to that of 
intact PRL, the biological activity of 22 kDa 
PRL remains to be investigated [25], In an 
initial study, a 16 kDa fragment was found 
to have a greater mammary mitogenic activ­
ity than intact PRL [18] but in a later report 
the opposite was found in rats [3], On the 
other hand, high molecular weight forms of 
PRL were detected in the pituitary gland 
and plasma of most species examined [14, 
27], They have been referred to as big-big 
(MW > 60 kDa) and big (MW « 45 kDa). 
The physiological significance of these 
larger forms is unknown because, in gen­
eral, their biopotency lower than that of 
native PRL [24, 26].
In the bitch, there is no documented 
information about the molecular profiles of 
circulating PRL in any stage of the estrous 
cycle. Certainly, the possibility exists that 
PRL variants may also occur in dogs. If so. 
eventual differences in the proportion of 
PRL forms (each of them endowed with dif­
ferent bioactivity/immunoreactivity ratios) 
among bitches, could explain, at least in 
part, the lack of consistency found in some 
bitches, between immunoassayable circu­
lating levels of PRL and the intensity of 
symptoms in some PRL-associated syn­
dromes, like pseudopregnancy [10-12, 15, 
20,22],
It was, therefore, of interest to determine 
whether in the bitch, PRL circulates as a 
single molecular entity or as multiple molec­
ular variants. A second point of interest was 
to compare the molecular profiles of serum 
PRL between covert and overt pseudopreg­
nant bitches. Since the circulating concen­
tration levels of both PRL and progesterone 
(P4) have been implicated in the etiology of 
pseudopregnancy [5-8], the serum concen­
trations of these hormones were compared 
between these two groups.
2. MATERIALS AND METHODS
2.1. Animals
Fifty-five privately owned cross- and 
pure-bred bitches aged 2 to 10 years and 
weighing 7 to 30 kg were used. They all had 
had their previous estrus between 8 and 
12 weeks prior to the commencement of the 
study. The bitches were divided into 
2 groups, taking into account the presence of 
overt pseudopregnancy (pseudopregnant 
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group [PSPT], n = 30) or absence of symp­
toms (covert pseudopregnancy; control 
group [CTRL], n = 25). Overt pseudopreg­
nancy was diagnosed based on the presence 
of mammary enlargement with milk secre­
tion, which was frequently associated with 
maternal behavior [6, 7],
2.2. Blood sampling
Blood samples for PRL and P4 determi­
nation were collected by peripheral (jugu- 
lar/cephalic/saphenous) venepuncture from 
9 and 11 am. Samples were centrifuged at 
4000 g for 15 min, serum obtained and 
stored at -20 °C until hormone assays were 
performed.
2.3. Hormone assays
Serum PRL was measured by a homolo­
gous end point enzymoimmunometric assay 
(Milenia, DPC®1, Bad Nauheim, Germany). 
The intra- and inter-assay coefficients of 
variation were 3.5 and 9.4%, respectively. 
The lowest limit of detection at 95% binding 
(sensitivity) was 0.5 ngmL-1. Semin P4 was 
measured by radioimmunoassay, using a 
solid phase kit (Coat-A-Count, DPC®1, Los 
Angeles, USA). For this kit, the sensitivity 
at 95% binding was 0.1 ng mL1 and the 
intra- and inter-assay coefficients of varia­
tion were 3.8 and 4.5%, respectively.
2.4. Gel chromatography
A total of 47 serum samples were used 
for chromatographic analysis. Samples were 
grouped according to the clinical status of 
animals (CTRL = C or PSPT = P) and their 
serum PRL levels (high PRL (H) > or low 
PRL (L) < 10 nginL1). Within each group, 
serum pools were prepared by mixing 
300 uL of each sample. The pools so gen­
erated were as follows:
- P-H: pooled sera from PSPT animals 
with high PRL levels (n =13).
- P-L: pooled sera from PSPT animals 
with low PRL levels (n = 9).
- C-H : pooled sera from CTRL animals 
with high PRL levels (n = 5).
- C-L: pooled sera from CTRL animals 
with low PRL levels (n = 20).
The serum pools were chromatographed 
on a Sephadex G-100 column (100 x 1.6 cm; 
Pharmacia, Uppsala, Sweden) equilibrated 
at 20 °C with 0.05 M phosphate-buffered 
saline, pH 7.4, containing 0.2% bovine 
serum albumin (BSA; Sigma, Saint-Louis, 
Missouri). The same buffer was used for 
elution. The column was calibrated with 
dextran blue (MW = 2 000 kDa), BSA (MW 
= 67 kDa) and 125I-hPRL (MW = 23 kDA) 
as previously described [14], Four-ml serum 
aliquots were loaded, in separate runs, onto 
the column and buffer was run through by 
means of a peristaltic pump at a flow 
rate of approximately 7.5 mL lr1. A total 
of 72 fractions of 2 lnL each were collected 
per run and were frozen until PRL determi­
nation.
2.5. Affinity chromatography
In order to separate glycosylated PRL 
forms, 1 mL sample was applied to a col­
umn of concanavalin A-Sepharose (100 x 
2.5 cm; Pharmacia, Uppsala). The con­
canavalin A-adsorbed material was eluted 
with 0.2 M methyl-D mannopyranoside 
(Sigma, Saint-Louis, Missouri) as previ­
ously described [14], Samples were kept 
frozen until PRL determination.
2.6. Statistical analysis
Data were analysed by least-squares 
means (LSM) analysis of the variance using 
the General Linear Model procedure (PROC 
GLM, SAS® [23]) for serum PRL and P4, 
the percentage of PRL variants and of 
G-PRL forms. The mathematical model 
included the main effect of group 
(PSPT/CTRL). The level of significance 
was set at 0.05.
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3. RESULTS
3.1. Chromatographic analysis 
of bitch sera
Gel chromatography revealed the pres­
ence of multiple molecular forms of 
immunoassayable PRL in bitch serum 
(Fig. 1). This molecular heterogeneity 
occured in both CTRL and PSPT animals, 
irrespective of their serum PRL levels. Four 
predominant molecular forms were identi­
fied. By analogy with human PRL, the four 
fractions were tentatively referred to as, 
big-big, big, native and fragmented, from 
the largest to the smallest. Big-big was larger 
than the BSA marker, whereas big was 
slightly smaller than BSA (67 kDa). The 
PRL fraction termed native had a molecular 
size very close to that of the hPRL marker 
(23 kDa) while the fragmented form was 
smaller than 20 kDa. The percentage of the 
big-big and big forms as well as the peaks 
probably associated with native and frag­
mented hormone were variable in the dif­
ferent serum pools (Fig. 2). However, no 
clear differences in relative abundance were 
evident among groups for any of the differ­
ent PRL variants.
A large proportion of glycosylated PRL 
was also detected. It constituted 69, 77, 70 
and 100% of total PRL for the P-H, P-L, 
C-H and C-L groups, respectively.
3.2. Serum PRL levels in CTRL 
and PSPT bitches
Serum PRL concentrations were signifi­
cantly higher inPSPT (13.8 ± 2.6 ngmL-1, 
range 0.5 to 80 ng mL1) than in CTRL 
bitches (6.3 ± 1.6 ng mL-1. range 0.5 to 
37.7 ng mL-1; p = 0.02 (Fig. 3). On the other 
hand, no significant differences were found 
in P4 concentrations between PSPT (1.3 ± 
0.3 ng mL-1) and CTRL (1.1 ± 0.3 ng mL-1; 
/? = 0.79).
4. DISCUSSION
Our results docmnent, for the first time, 
that in the dog there are different molecular
Figure 1. Chromatographic profile for serum PRL in bitches. The chromatogram shown represents 
a typical PRL profile observed in the senim of bitches. This example corresponds to a serum pool from 
C-H animals. Hie sample was run on a Sephadex G-100 column. Pool volume seeded was 4 mL. Hie 
names given to the different PRL peaks were assigned by analogy with known human PRL vari­
ants of roughly similar sizes. Markers: DB = dextran blue, MW 2000 kDa; BSA = bovine serum albu­
min, MW 67 kDa: 11PRL = 125I-liPRL, MW 23 kDa. For further details see the text.
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EXPERIMENTAL GROUPS
Figure 2. Distribution of PRL variants in the dif­
ferent serum pools. Percentages refer to the sum 
of all peaks for each serum pool. P-H: PSP with 
high PRL levels; P-L: PSP with low PRL; C-H: 
CTRL with high PRL; C-L: CTRL with low 
PRL. For further details see the text.
Figure 3. Serum PRL levels in diestrous bitches. 
Covert (CTRL) and overt PSPT bitches were 
bled under comparable experimental conditions.
forms of circulating PRL, thus enlarging the 
list of species known to possess multiple 
molecular PRL forms in the circulation. 
Nevertheless, the present results should be 
regarded as an initial study, where no exten­
sive biochemical or biological characteri­
zation of the different fractions was 
attempted. Since in other species circulat­
ing PRL is known to occur in multiple 
molecular forms, each of them endowed 
with different bioactivity levels, it would 
be of interest to characterize the bioactiv­
ity to immunoreactivity ratio of the four 
PRL variants described here.
Although PRL was long regarded as a 
non glycoprotein hormone, it is now known 
that a proportion of PRL molecules is actu­
ally glycosylated, with a degree of glyco­
sylation that varies among species, ranging 
from a very low level to more than 50%. 
Thus, in humans glycosylated PRL (G-PRL) 
has been reported to be up to 20. 32 and 
50% in plasma in different studies [2, 4, 16] 
while in the same biologic fluid from rats 
it was reported to be 60% [1], The biologi­
cal activity of G-PRL in some of the classi­
cal tests for the hormone, such as pigeon 
crop sac stimulation, Nb2 lymphoma cell 
proliferation and mammary casein synthesis 
is similar to or lower than non glycosylated 
PRL [16], However, some later studies 
claimed greater than normal pigeon crop 
sac stimulating activity for porcine G-PRL 
[21], Receptor binding activity and immuno­
logic cross-reactivity are also greatly 
reduced as a result of glycosylation, thus it 
has been suggested that glycosylation may 
down regulate PRL action at target tissues 
[25], Glycosylation seems to facilitate 
proteolytic cleavage of the molecule to a 
17 kDa form, and thus may serve a role in 
regulation of the processing of PRL [25], 
In this context, it is of interest that our 
bitches displayed a higher proportion of cir­
culating G-PRL than most species studied so 
far. Whether this high degree of glycolsy- 
lation of canine PRL plays any physiologi­
cal role, remains to be investigated.
Our finding of significantly higher PRL 
levels in PSPT than in CTRL bitches is in 
agreement with some previous reports [9. 
19], although a number of other studies have 
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not detected significant differences in PRL 
levels between overt and covert PSPT 
bitches [11. 12, 15, 20, 22], Indeed, a uni­
versal serum PRL threshold for triggering 
pseudopregnancy in the bitch is unlikely to 
exist. This is in line with studies in women 
where, in some individuals, no correlation 
was detected between typical signs of hyper­
prolactinemia and serum PRL concentra­
tions [13, 14, 27],
The present study originated from our 
interest to elucidate a paradox frequently 
found in bitches: While PRL is generally 
accepted to play a key role in the genesis of 
pseudopregnancy in diestrous bitches [7, 
9-11,17,19,22], it is a fairly frequent find­
ing that animals with high (immunoas- 
sayable) PRL levels do not develop overt 
pseudopregnancy symptoms while others 
with lower serum PRL do (this can be appre­
ciated in Fig. 3). We reasoned that if in the 
bitch, PRL circulated under multiple molec­
ular forms of varying bioactivity, then overt 
PSPT animals with low immunoassayable 
serum PRL could possess a prevalence of 
PRL variants with high bioactivity to 
immunoreactivity ratio, with the opposite 
happening in covert PSPT animals with rel­
atively high PRL levels. The present results 
confirm the first part of our hypothesis; that 
is, canine PRL circulates under multiple 
molecular forms. However, the data reveal a 
rough similarity in the distribution of PRL 
forms in PSPT and CTRL bitches, irrespec­
tive of their serum PRL levels, thus failing to 
support the second part of our hypothesis.
We conclude that in dogs, circulating 
PRL occurs in multiple molecular forms and 
that the relative abundance of these forms in 
bitches is comparable between bitches with 
and without overt pseudopregnancy.
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